Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...
MedPage Today on MSN
One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk
Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...
The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...
Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...
MedPage Today on MSN
GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.
Zealand Pharma plans to launch five obesity and related drugs by 2030 as the Danish company tries to break into the lucrative ...
US Weekly on MSN
‘Love Is Blind’ Alum Irina Solomonova Reveals GLP-1 Use: ‘This Isn’t a Quick Fix Thing for Me’
Love Is Blind alum Irina Solomonova has been using a GLP-1 to slim down. “I’m finishing my first month on GLP-1s. I’m on ...
College students may plan an appointment during winter break and inquire about GLP-1 medications. What should a primary care ...
From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...
GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results